Dan Mandell, GRO Biosciences CEO
George Church spinout raises $60M for protein therapies from genomically recoded organisms
A biotech startup trying to expand the limited palette that nature uses to make proteins has raised funds to test its creations in humans for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
